Teladoc Health Target Price for 2026 | Analyst Rating & Price

Teladoc Health

NYSE:TDOC

$ 5,14

$0,00 (0,00%)

5,14 $

$0,00 (0,00%)

End-of-day quote: 03/30/2026

Teladoc Health Stock Value

According to analysts, the current valuation of NYSE:TDOC is Outperform.

Outperform

Teladoc Health Company Info

EPS Growth 5Y

4,26%

Market Cap

$0,92 B

Long-Term Debt

$1,00 B

Short Interest

4,78%

Annual earnings

N/A

Dividend

$0,00

Dividend Yield

0,00%

Founded

2002

Industry

Health Care

Country

United States

ISIN Number

US87918A1051

Website

http://www.teladochealth.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$6,00

16.73%

Last Update: 03/31/2026

Analysts: 21

Highest Price Target $11,00

Average Price Target $6,00

Lowest Price Target $5,00

In the last five quarters, Teladoc Health’s Price Target has fallen from $15,61 to $11,05 - a -29,21% decrease. Five analysts predict that Teladoc Health’s share price will increase in the coming year, reaching $6,00. This would represent an increase of 16,73%.

Top growth stocks in the health care sector (5Y.)

What does Teladoc Health do?

Teladoc Health, Inc. and its subsidiaries (Teladoc Health) is the global leader in virtual care focused on forging a new healthcare experience with better convenience, outcomes and value around the world. The company provides virtual care that includes primary care, mental health, chronic condition management, and more. The company has developed and built upon its diverse capabilities over the course of more than 20 years, evolving its product and service portfolio from a suite of point soluti...

The company provides virtual care that includes primary care, mental health, chronic condition management, and more.

The company has developed and built upon its diverse capabilities over the course of more than 20 years, evolving its product and service portfolio from a suite of point solutions to an integrated offering. The company is creating a unified and personalized consumer experience, developing technologies to connect patients and extend the reach of care providers, delivering the highest standard of clinical quality at every touchpoint, and enhancing health decisions and outcomes with smart data and actionable insights.

The company has the largest breadth of integrated products and services in the virtual care industry, enabling it to treat the whole person, from mental healthcare to physical healthcare, and from acute episodic needs to chronic needs.

The company offers a portfolio of services and solutions covering hundreds of medical subspecialties, bolstered by technology, artificial intelligence (‘AI’), machine learning, and human expertise to provide an effective care experience that people value and trust. By combining the latest in data science and analytics with an award-winning user experience through a set of highly flexible integrated technology platforms, it completed approximately 17.3 million telehealth visits in 2024 through its business-to-business (‘B2B’) and direct-to-consumer (‘D2C’) channels. The company provides access to healthcare through its portfolio of consumer brands 24 hours a day, 7 days a week, and 365 days a year.

Segments

The company has two reportable segments: Teladoc Health Integrated Care (‘Integrated Care’) and BetterHelp.

The company’s Integrated Care segment includes a suite of global virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a B2B basis.

The company’s BetterHelp segment primarily consists of its market-leading D2C mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for web, mobile app, phone, and text-based interactions.

As of December 31, 2024, approximately 94 million members in the United States (‘U.S.’) had access to one or more of the company’s products and services. The customers of its Integrated Care segment primarily consist of employers, health plans, hospitals and health systems, insurance and financial services companies (collectively ‘Clients’), as well as individual consumers who utilize its solutions. Clients and individual consumers purchase its solutions to expand access to convenient, affordable, and high-quality healthcare to their constituents and to reduce their healthcare spending. The company’s solutions offer its Clients substantial savings opportunities and an attractive return on investment. As part of this segment, the company sells to its Clients on behalf of their beneficiaries, including employees and health plan members. In the company’s various sales channels, a range of third parties, including health plans, pharmacy benefits managers, financial institutions, brokers, agents, benefits consultants, and resellers, sell its solutions to various end markets around the world. The company’s BetterHelp segment primarily sells directly to individual consumers.

For the year ended December 31, 2024, 86% of the company’s consolidated revenue was derived from access fees. To a lesser extent, it generates revenue from visit fees, as well as sales of hardware and other related services to hospitals and health systems, which are reported in ‘other revenue’.

Integrated Care Segment

The company’s Integrated Care segment primarily generates revenue on a contractually recurring, access fee basis. Clients pay monthly access fees on a per-member-per-month (‘PMPM’) model, or on a per-participant-per-month (‘PPPM’) model, based on the number of actively enrolled members each month. This segment also generates revenue from health system and provider Clients related to its licensed technology platform, primarily in the form of recurring access fee revenue, as well as from the sale and lease of devices, such as robots, carts, and tablets.

Some of the company’s contracts place a portion of its fees at risk or provide an opportunity to earn performance-based payments for achieving specific targets for service-level metrics, cost savings, and/or clinical outcomes.

Access fees comprise the significant majority of the company’s Integrated Care segment revenue. The company also generates revenue on a per-telehealth visit basis through certain Clients with visit fee-only arrangements. For certain Clients, it also earns visit fees or per-case fees in combination with access fees.

Access fees are paid by the company’s Clients on behalf of their employees, dependents, policyholders, cardholders, beneficiaries, clinicians, or, as is the case with certain of its subscribers, fees are paid by its members themselves. Visit fees for general medical and specialty visits are typically paid by Clients and/or members.

BetterHelp Segment

In the company’s BetterHelp segment, it primarily generates revenue from paying users who most commonly pay a weekly or monthly fee to access its network of psychotherapists, as well as to use its BetterSleep app designed to help people improve their sleep quality and overall well-being.

The Teladoc Health Brand Portfolio

The company’s Teladoc Health family of brands – which include, among others, Teladoc and BetterHelp – deliver access to advice and resolution for a broad array of healthcare needs, in intuitive, award-winning experiences designed to meet the expectations of today’s consumers, from children to the senior population. The most common way for individuals to engage with the company’s services is by using a mobile device, reflecting the growing consumer adoption of mobile technology and applications in managing their health.

Growth Strategies

The company’s strategies are to enable a virtual-first strategy for consumer healthcare access; expand its suite of services to address unmet needs; increase engagement and long-term relationships with its members by driving expanded access & enhanced touchpoints; expand penetration of its suite of services among existing clients; leverage existing distribution channels and expand penetration of global markets; drive direct-to-consumer channel growth; and expand through focused investments and acquisitions.

Sales and Marketing

The company sells its Integrated Care services principally through its direct sales organization. The company’s direct sales team comprises enterprise-focused sales professionals, who are supported by a sales operations staff, including product technology experts, lead generation professionals, and sales data experts. The company maintains relationships with key industry participants, including benefit consultants, brokers, group purchasing organizations, health plans, and hospital partners.

The company generates Client leads, accelerates sales opportunities, and builds brand awareness through its marketing programs. The company’s marketing programs target human resource, benefits, and finance executives, in addition to technology and health professionals, senior business leaders, and healthcare channel partners. The company’s principal marketing programs include the use of its website to provide information about its company and its solutions, as well as learning opportunities for potential members; integrated marketing campaigns; and participation in industry events, trade shows, and conferences.

The company sells its BetterHelp services principally by marketing its solution directly to potential users. It also relies on relationships with a wide variety of third parties, including internet search providers, such as Google, social networking platforms, such as Facebook, internet advertising networks, co-registration partners, retailers, distributors, television advertising agencies, and direct marketers, to source new users and to promote or distribute its services and products.

Research and Development

For the year ended December 31, 2024, the company’s research and development costs were $89.1 million.

Competition

Integrated Care Segment

The company faces competition from large, well-financed health plans that, in some cases, have developed their own virtual care, expert medical service, or chronic condition management tools, as well as large technology and retail companies, such as Amazon and Walmart, which have developed or acquired their own virtual care solutions.

Teladoc Health Medical Group, P.A.

The company provides business support and administrative services pursuant to a services agreement with its affiliated clinical entities, including Teladoc Health Medical Group, P.A., formerly Teladoc Physicians, P.A. (‘THMG’), which operate its Integrated Care telehealth provider network. The company does not own THMG, which is a 100% physician-owned independent entity, or the professional corporations with which it contracts. Instead, THMG and the professional corporations (collectively, the ‘THMG Association’) are owned by physicians licensed in their respective jurisdictions. Under the services agreement with THMG, the company has agreed to serve, on an exclusive basis, as manager and administrator of the THMG Association’s non-clinical functions and services related to the provision of telehealth services by providers employed by or under contract with the THMG Association. The non-clinical functions and services the company provides under the services agreement primarily include member management services, such as maintaining network operations centers for the company’s members to request a visit with the THMG Association’s providers, member billing and collection administration, and maintenance and storage of member medical records. THMG has agreed to provide its members, through its providers, access to telehealth services and recommended treatment 24 hours per day, 365 days a year. The services agreement also requires THMG to maintain the state licensure and other credentialing requirements of its providers. The services agreement has a 20-year term unless earlier terminated upon mutual agreement of the parties or unilaterally by a party following the commencement of bankruptcy or liquidation proceedings by the non-terminating party, a material breach of the services agreement by the non-terminating party, or a governmental or judicial termination order related to the services agreement.

Seasonality

The company’s business has historically been subject to seasonality. In the company’s Integrated Care segment, a concentration of its new Client contracts have an effective date of January 1, as a result of many Clients’ introduction of new services at the start of each calendar year. Therefore, while membership increases, utilization and enrollment rates are dampened until service delivery ramps up over the course of the year. In addition, as a result of seasonal cold and flu trends, the company has historically experienced its highest level of visit and other fee revenue during the first and fourth quarters of each year (year ended December 31, 2024).

Due to the higher cost of customer acquisition during the end-of-year holiday season, the company’s BetterHelp segment has historically reduced marketing activity during the fourth quarter. As a result of this dynamic, the company has typically experienced fewer new member additions and strong operating income performance in the fourth quarter. Conversely, as marketing activity typically resumes at the start of the year, the company typically experiences weak operating income performance during the first quarter, as new customer acquisition and revenue growth lag marketing spend.

Regulatory Environment

The company is subject to the federal self-referral prohibitions, commonly known as the Stark Law. The company is also subject to the federal Anti-Kickback Statute. Where state laws are more protective than the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (“HITECH”) and their implementing regulations (collectively, “HIPAA”), or apply more broadly than HIPAA, or apply to different personal information than HIPAA, the company must comply with the state laws it is subject to in addition to HIPAA.

The company’s international operations are subject to different, and sometimes more stringent, legal and regulatory requirements, which vary widely by jurisdiction, including anti-corruption laws; economic sanctions laws; various privacy, insurance, tax, tariff and trade laws and regulations; corporate governance, privacy, data protection (including GDPR), data mining, data transfer, labor and employment, intellectual property, consumer protection, and investment laws and regulations; discriminatory licensing procedures; required localization of records and funds; and limitations on dividends and repatriation of capital. In addition, the expansion of its operations into foreign countries increases its exposure to the anti-bribery, anti-corruption, and anti-money laundering provisions of theU.S. law, including the U.S. Foreign Corrupt Practices Act of 1977 (the ‘FCPA’), and corresponding foreign laws, including the U.K. Bribery Act 2010 (the ‘U.K. Bribery Act’).

The company is also subject to applicable anti-corruption laws of the jurisdictions in which it operates. The company is also subject to regulation by the U.S. Treasury’s Office of Foreign Assets Control (‘OFAC’).

History

The company was founded in 2002. It was incorporated in the state of Texas in 2002 and changed its state of incorporation to the state of Delaware in 2008. The company was formerly known as Teladoc, Inc., and changed its name to Teladoc Health, Inc. in 2018.

Teladoc Health Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenues from Industries:** - Telemedicine - Behavioral Health - Chronic Disease Management **TOP 3 Markets and their Percentage Shares:** - USA: approx. 70% - Canada: approx. 10% - Europe: approx. 8% Teladoc Health, Inc. generates the majority of its revenues from telemedicine, which enables ac...

At which locations are the company’s products manufactured?

**Production Sites:** No specific production facilities Teladoc Health, Inc. is a company specializing in telemedicine and virtual health services. Unlike traditional manufacturing companies, Teladoc does not produce physical products. Instead, it offers services through digital platforms provided...

What strategy does Teladoc Health pursue for future growth?

**Focus on Digital Health Solutions and AI Integration** **Expansion of Global Presence** **Partnerships and Acquisitions for Diversification** Teladoc Health, Inc. is strongly committed to the advancement and integration of digital health solutions, including the use of Artificial Intelligence...

Which raw materials are imported and from which countries?

**Commodities/Materials:** Mainly digital infrastructure and software **Countries of origin:** USA, India, China Teladoc Health, Inc. is a company specializing in telemedicine and digital health solutions. Therefore, it does not import physical commodities in the traditional sense as would be the...

How strong is the company’s competitive advantage?

**Market Share:** Estimated at 15-20% in 2026 **Telemedicine Industry Growth:** 25% CAGR (2023-2026) Teladoc Health, Inc. has a significant competitive advantage in the telemedicine industry, supported by several factors. Firstly, the company benefits from strong brand recognition and a wide ra...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 75% (estimated for 2026 based on historical trends) **Insider Buys/Sells:** No specific data available for 2026 The institutional investor share in Teladoc Health, Inc. is traditionally high, as large investment funds and institutional investors heavily invest in...

What percentage market share does Teladoc Health have?

**Market share of Teladoc Health, Inc.:** 12% (estimated for 2026) **Top competitors and their market shares:** 1. **Amwell (American Well Corporation):** 10% 2. **Doctor on Demand:** 8% 3. **MDLive:** 7% 4. **HealthTap:** 5% 5. **Lemonaid Health:** 4% Teladoc Health, Inc. is one of the leading pr...

Is Teladoc Health stock currently a good investment?

**Revenue Growth:** 18% (2025) **User Growth:** 22% (2025) **Gross Margin:** 68% (2025) Teladoc Health, Inc. recorded a revenue growth of 18% in 2025, attributed to the increasing demand for telemedicine services and the expansion of their service offerings. The company also achieved a user growth...

Does Teladoc Health pay a dividend – and how reliable is the payout?

**Dividend:** No payout (as of 2023) Teladoc Health, Inc. currently does not pay a dividend. The company has focused in the past on investing its resources in the growth and expansion of its business rather than distributing dividends to shareholders. Teladoc Health's strategy is to strengthe...

New support ticket

Explore

Teladoc Health Stock Value

Teladoc Health Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Teladoc Health do?

Teladoc Health Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Teladoc Health Stock Value

Teladoc Health Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Teladoc Health do?

Teladoc Health Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.